{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:38:54Z","timestamp":1792557534376,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe the clinical presentation, treatments and prognosis of gastrointestinal (GI) involvement in adult IgA vasculitis (IgAV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 260 adults with IgAV included in a French multicentre retrospective survey were analysed. Presentation and outcomes of patients with (GI+) and without (GI-) GI involvement were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred and thirty-seven (53%) patients had GI involvement. Initial manifestations were abdominal pain in 99%, intestinal bleeding in 31%, diarrhoea in 26% and acute surgical abdomen in only 4%. Abdominal imaging revealed thickening of intestinal wall in 61%, and endoscopies revealed abnormalities in 87%, mostly mucosal ulcerations. GI+ vs GI- patients were younger (46 \u00b1 18 vs 54 \u00b1 18\u2009years; P\u2009=\u20090.0004), had more constitutional symptoms (43% vs 23%; P\u2009=\u20090.0005) and joint involvement (72 vs 50%; P\u2009=\u20090.0002), and higher CRP levels (3.7 vs 1.9\u2009mg\/dl; P\u2009=\u20090.001). Clinical response and relapse rates were comparable between groups, and all causes mortality (2 vs 4%) and IgAV-related mortality (1% vs 2%) as well. GI-related deaths were due to intestinal perforation and mesenteric ischaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GI involvement is frequent in adult IgAV. GI involvement is frequent in adult IgAV. Mortality is not uncommon but does not seem to be specifically related to GI. Immunosuppressants should not be preferred as first-line therapy for GI+ patients but may be required in case of acute surgical abdomen.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa104","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T15:16:29Z","timestamp":1581520589000},"page":"3050-3057","source":"Crossref","is-referenced-by-count":60,"title":["Gastrointestinal involvement in adult IgA vasculitis (Henoch-Sch\u00f6nlein purpura): updated picture from a French multicentre and retrospective series of 260 cases"],"prefix":"10.1093","volume":"59","author":[{"given":"Alexandra","family":"Audemard-Verger","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, CHRU Tours, University of Tours, Tours"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evang\u00e9line","family":"Pillebout","sequence":"additional","affiliation":[{"name":"Department of Nephrology, H\u00f4pital Saint-Louis, Assistance Publique-H\u00f4pitaux de Paris (AP-HP)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, H\u00f4pital Piti\u00e9-Salp\u00e9tri\u00e8re"},{"name":"Inflammation-Immunopathology-Biotherapy Department (DHU i2B), UMR 7211, UPMC Universit\u00e9 Paris 06, Sorbonne Universit\u00e9s, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Jourde-Chiche","sequence":"additional","affiliation":[{"name":"Department of Nephrology, CHU, Marseille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Lioger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hopital Saint Louis, APHP, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8932-3169","authenticated-orcid":false,"given":"Nihal","family":"Martis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU, Nice"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Moulis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU, Toulouse"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Rivi\u00e8re","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU, Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Baldolli","sequence":"additional","affiliation":[{"name":"Department of infectious Disease, CHU, Caen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Girard","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU Edouard Herriot, Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Goutte","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU, Saint-Etienne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie Le","family":"Gouellec","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Nephrology, CH, Valenciennes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Raffray","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU, La R\u00e9union"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-8423","authenticated-orcid":false,"given":"Geoffrey","family":"Urbanski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Sanges","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Interne et Immunologie Clinique, CHU"},{"name":"University Lille, INSERM, U995\u2014LIRIC\u2014Lille Inflammation Research International Centre, Lille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Maurier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pitaux Priv\u00e9s, Metz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[{"name":"Department of Nephrology, H\u00f4pital Europ\u00e9en Georges Pompidou, AP-HP"},{"name":"Universit\u00e9 Paris Descartes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU, Caen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes"},{"name":"Department of Internal Medicine"},{"name":"National Referral Centre for Systemic and Autoimmune Diseases, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Maillot","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, CHRU Tours, University of Tours, Tours"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes"},{"name":"Department of Internal Medicine"},{"name":"National Referral Centre for Systemic and Autoimmune Diseases, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"French Vasculitis Study Group (FVSG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"2020092605144376900_keaa104-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2020092605144376900_keaa104-B2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"key":"2020092605144376900_keaa104-B3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0889-857X(05)70232-5","article-title":"Epidemiology of the vasculitides","volume":"27","author":"Gonz\u00e1lez-Gay","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"2020092605144376900_keaa104-B4","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.ejim.2017.05.025","article-title":"Positive predictive value of hospital discharge diagnosis code to identify immunoglobulin A vasculitis in France: a validation study","volume":"43","author":"Deshayes","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2020092605144376900_keaa104-B5","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1038\/s41598-017-03915-2","article-title":"A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis","volume":"7","author":"L\u00f3pez-Mej\u00edas","year":"2017","journal-title":"Sci Rep"},{"key":"2020092605144376900_keaa104-B6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/art.38979","article-title":"HLA-DRB1 association with Henoch-Schonlein purpura","volume":"67","author":"L\u00f3pez-Mej\u00edas","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2020092605144376900_keaa104-B7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/sarh.2002.33980","article-title":"Henoch-Schonlein purpura in children and adults: clinical differences in a defined population","volume":"32","author":"Garcia-Porrua","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"2020092605144376900_keaa104-B8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/art.1780400513","article-title":"Henoch-Sch\u00f6nlein purpura in adulthood and childhood: two different expressions of the same syndrome","volume":"40","author":"Blanco","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2020092605144376900_keaa104-B9","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1651-2227.2004.tb02623.x","article-title":"Gastrointestinal manifestations in Henoch-Sch\u00f6nlein purpura: a review of 261 patients","volume":"93","author":"Chang","year":"2007","journal-title":"Acta Paediatr"},{"key":"2020092605144376900_keaa104-B10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3346\/jkms.2014.29.2.198","article-title":"Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Sch\u00f6nlein purpura","volume":"29","author":"Kang","year":"2014","journal-title":"J Korean Med Sci"},{"key":"2020092605144376900_keaa104-B11","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/rheumatology\/kev122","article-title":"Patient age, gender and extent of purpura may suggest short-term outcomes in adults with IgA vasculitis","volume":"54","author":"Ho\u010devar","year":"2015","journal-title":"Rheumatology"},{"key":"2020092605144376900_keaa104-B12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MD.0000000000000019","article-title":"Henoch-Sch\u00f6nlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center","volume":"93","author":"Calvo-R\u00edo","year":"2014","journal-title":"Medicine"},{"key":"2020092605144376900_keaa104-B13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","article-title":"IgA vasculitis (Henoch-Sh\u00f6nlein purpura) in adults: diagnostic and therapeutic aspects","volume":"14","author":"Audemard-Verger","year":"2015","journal-title":"Autoimmun Rev"},{"key":"2020092605144376900_keaa104-B14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","article-title":"Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Medicine"},{"key":"2020092605144376900_keaa104-B15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine"},{"key":"2020092605144376900_keaa104-B16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine"},{"key":"2020092605144376900_keaa104-B17","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/art.40178","article-title":"Characteristics and management of IgA vasculitis (Henoch-Sch\u00f6nlein) in adults: data From 260 patients included in a French Multicenter Retrospective Survey","volume":"69","author":"Audemard-Verger","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020092605144376900_keaa104-B18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"2020092605144376900_keaa104-B19","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1136\/gut.2010.218123","article-title":"Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related systemic vasculitis: a case-control study from a single-centre cohort of 163 patients","volume":"59","author":"Terrier","year":"2010","journal-title":"Gut"},{"key":"2020092605144376900_keaa104-B20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0016-5107(02)70376-3","article-title":"GI involvement in Henoch-Sch\u00f6nlein purpura","volume":"56","author":"Esaki","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"2020092605144376900_keaa104-B21","doi-asserted-by":"crossref","first-page":"e4217","DOI":"10.1097\/MD.0000000000004217","article-title":"Relapses in patients with Henoch-Sch\u00f6nlein purpura: analysis of 417 patients from a single center","volume":"95","author":"Calvo-R\u00edo","year":"2016","journal-title":"Medicine"},{"key":"2020092605144376900_keaa104-B22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-2-7","article-title":"A randomized, placebo-controlled trial of prednisone in early Henoch Sch\u00f6nlein Purpura [ISRCTN85109383]","volume":"2","author":"Huber","year":"2004","journal-title":"BMC Med"},{"key":"2020092605144376900_keaa104-B23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","article-title":"Early prednisone therapy in Henoch-Sch\u00f6nlein purpura: a randomized, double-blind, placebo-controlled trial","volume":"149","author":"Ronkainen","year":"2006","journal-title":"J Pediatr"},{"key":"2020092605144376900_keaa104-B24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00467-012-2106-z","article-title":"Outcome of Henoch-Sch\u00f6nlein purpura 8 years after treatment with a placebo or prednisone at disease onset","volume":"27","author":"Jauhola","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"2020092605144376900_keaa104-B25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.2010.150","article-title":"Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Sch\u00f6nlein Purpura","volume":"78","author":"Pillebout","year":"2010","journal-title":"Kidney Int"},{"key":"2020092605144376900_keaa104-B26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40339","article-title":"Brief Report: rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Sch\u00f6nlein)","volume":"70","author":"Maritati","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2020092605144376900_keaa104-B27","first-page":"1014","article-title":"Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Sch\u00f6nlein purpura","volume":"28","author":"Amoli","year":"2001","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/3050\/33794883\/keaa104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/3050\/33794883\/keaa104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T05:15:04Z","timestamp":1601097304000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/3050\/5811392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,3,24]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa104","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,3,24]]}}}